Immunotherapy for the treatment and prevention of inflammatory bowel disease

A polypeptide comprising two or more flagellin T-cell receptor (TCR) epitopes selected from the group consisting of SEQ ID NO:

• 1, SEQ ID NO:
• 2, SEQ ID NO:
• 3, SEQ ID NO:
• 6, SEQ ID NO:
• 7 SEQ ID NO:
• 8, SEQ ID NO:
• 9, SEQ ID NO:
• 10, SEQ ID NO:
• 11, SEQ ID NO:
• 12, SEQ ID NO:
• 13, SEQ ID NO:
• 14, SEQ ID NO:
• 15, SEQ ID NO:
• 16, SEQ ID NO:
• 17, SEQ ID NO:
• 18, SEQ ID NO:
• 19, SEQ ID NO:
• 20, SEQ ID NO:
• 21, SEQ ID NO:
• 22, SEQ ID NO:
• 23, SEQ ID NO:
• 24, SEQ ID NO:
• 25, SEQ ID NO:
• 26, SEQ ID NO;
• 27, SEQ ID NO:
• 34, SEQ ID NO:
• 35, SEQ ID NO:
• 36, and SEQ ID NO:
• 37.